Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Gastroenterology|April 1, 1994
Platelets circulate in an activated state in inflammatory bowel diseaseC E Collins, M R Cahill, A C Newland, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trialA D de Silva, E Tsironi, R M Feakins, et al.
Alimentary Pharmacology & Therapeutics|September 13, 2001
Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's diseaseE Carty, D S Rampton, H Schneider, et al.
International Journal of Colorectal Disease|September 1, 2005
Synchronous colectomy and caesarean section for fulminant ulcerative colitis: case report and review of the literatureA I Haq, A Sahai, S Hallwoth, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1996
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel diseaseC E Collins, M J Benson, W R Burnham, et al.
Clinical and Experimental Immunology|November 1, 1992
Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitisT R Stevens, V R Winrow, D R Blake, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro studyL Langmead, C Dawson, C Hawkins, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1992
Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitisD J Gertner, D S Rampton, T R Stevens, et al.
Histopathology|October 8, 1998
Appendiceal inflammation in ulcerative colitisI S Scott, M Sheaff, A Coumbe, et al.
Gastroenterology|May 1, 1983
Effect of colonic perfusion with sulfated and nonsulfated bile acids on mucosal structure and function in the ratN F Breuer, D S Rampton, A Tammar, et al.
Pageof 11